PET of αvβ3-integrin and αvβ5-integrin expression with 18F-fluciclatide for assessment of response to targeted therapy: Ready for prime time?

Ambros J. Beer, Markus Schwaiger

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations
Original languageEnglish
Pages (from-to)335-337
Number of pages3
JournalJournal of Nuclear Medicine
Volume52
Issue number3
DOIs
StatePublished - 1 Mar 2011

Cite this